For the discovery of CoV-2 particle entry in absence of ACE2 and genome-wide gain-of-function screening to identify new secondary receptors/co-receptors/auxiliary proteins that facilitate viral entry/fusion.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$0Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Patrick GiguèreResearch Location
CanadaLead Research Institution
University of OttawaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
Pathogen morphology, shedding & natural historySpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
For the discovery of CoV-2 particle entry in absence of ACE2 and genome-wide gain-of-function screening to identify new secondary receptors/co-receptors/auxiliary proteins that facilitate viral entry/fusion.